FindTrial
Sign In

photopheresis

DEVICE5 trials

Sponsors

Eastern Cooperative Oncology Group, Boston University, Hannover Medical School, M.D. Anderson Cancer Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Conditions

Bronchiolitis ObliteransCutaneous T-Cell LymphomaGraft Versus Host DiseaseLeukemiaLung Transplant RejectionMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms

Phase 1

Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma
CompletedNCT00306969
Boston UniversityCutaneous T-Cell Lymphoma
Start: 2001-12-31End: 2004-04-30Target: 18Updated: 2006-03-27

Phase 2

Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes
CompletedNCT00045305
Eastern Cooperative Oncology GroupLeukemia, Myelodysplastic/Myeloproliferative Neoplasms, Myelodysplastic Syndromes
Start: 2006-10-24End: 2014-09-30Updated: 2023-06-28
Photopheresis for the Treatment of Acute Graft Versus Host Disease
CompletedNCT00609609
M.D. Anderson Cancer CenterGraft Versus Host Disease
Start: 2008-01-31End: 2016-01-31Updated: 2018-06-04

Unknown Phase

Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation
TerminatedNCT00502554
Hannover Medical SchoolBronchiolitis Obliterans
Start: 2007-08-31End: 2010-03-31Updated: 2011-07-26
Extracorporeal Photopheresis in Lung Transplant Rejection for Cystic Fibrosis (CF) Patients
NCT03500575
Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoLung Transplant Rejection
Start: 2018-05-20End: 2021-12-20Target: 24Updated: 2018-05-11

Related Papers

Extracorporeal photopheresis as induction therapy in lung transplantation for cystic fibrosis: a pilot randomized trial
Frontiers in Immunology2025-05-16